Shoshana Shendelman - Applied Therapeutics Founder, Directors
| APLT Stock | USD 1.69 0.06 3.43% |
Insider
Shoshana Shendelman is Founder, Directors of Applied Therapeutics
| Age | 45 |
| Address | 545 Fifth Avenue, New York, NY, United States, 10017 |
| Phone | 212 220 9226 |
| Web | https://www.appliedtherapeutics.com |
Latest Insider Transactions
Shoshana Shendelman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Shoshana Shendelman against Applied Therapeutics stock is an integral part of due diligence when investing in Applied Therapeutics. Shoshana Shendelman insider activity provides valuable insight into whether Applied Therapeutics is net buyers or sellers over its current business cycle. Note, Applied Therapeutics insiders must abide by specific rules, including filing SEC forms every time they buy or sell Applied Therapeutics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Shoshana Shendelman over three months ago Disposition of 119591 shares by Shoshana Shendelman of Applied Therapeutics at 5.93 subject to Rule 16b-3 | ||
Shoshana Shendelman over three months ago Disposition of 357423 shares by Shoshana Shendelman of Applied Therapeutics at 6.18 subject to Rule 16b-3 | ||
Shoshana Shendelman over three months ago Disposition of 300000 shares by Shoshana Shendelman of Applied Therapeutics at 5.98 subject to Rule 16b-3 | ||
Shoshana Shendelman over three months ago Disposition of 747886 shares by Shoshana Shendelman of Applied Therapeutics subject to Rule 16b-3 |
Applied Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.7601) % which means that it has lost $0.7601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7339) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Applied Therapeutics' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 7.33 in 2024, whereas Return On Tangible Assets are likely to drop (2.29) in 2024. At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 56.5 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 681.3 K in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carrie Cox | Candel Therapeutics | 66 | |
| MD MS | Candel Therapeutics | 53 | |
| LLM JD | Candel Therapeutics | 63 | |
| MBA JD | Cardio Diagnostics Holdings | 60 | |
| Philip Lee | Senti Biosciences | 42 | |
| MPA MD | Unicycive Therapeutics | 51 | |
| Susan Kahlert | Senti Biosciences | N/A | |
| Inf MD | Candel Therapeutics | 64 | |
| Nathan Caffo | Candel Therapeutics | 55 | |
| Ileen Winick | Candel Therapeutics | N/A | |
| Francesca MD | Candel Therapeutics | 46 | |
| John CPA | Unicycive Therapeutics | 62 | |
| James Collins | Senti Biosciences | 58 | |
| Meeshanthini Dogan | Cardio Diagnostics Holdings | 35 | |
| Jason Amello | Candel Therapeutics | 56 | |
| Deborah Knobelman | Senti Biosciences | 50 | |
| Seshu Tyagarajan | Candel Therapeutics | 56 | |
| Wilson Wong | Senti Biosciences | N/A | |
| FMEDSCI MD | Candel Therapeutics | 62 | |
| Timur Dogan | Cardio Diagnostics Holdings | 36 | |
Management Performance
| Return On Equity | -4.73 | ||||
| Return On Asset | -0.76 |
Applied Therapeutics Leadership Team
Elected by the shareholders, the Applied Therapeutics' board of directors comprises two types of representatives: Applied Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Applied. The board's role is to monitor Applied Therapeutics' management team and ensure that shareholders' interests are well served. Applied Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Applied Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Riccardo MD, Chief Officer | ||
| Chids Mahadevan, Sr Officer | ||
| Steven Ortega, Chief Officer | ||
| Constantine Chinoporos, COO Officer | ||
| Catherine Thorpe, Chief Officer | ||
| Adam Hansard, Chief Officer | ||
| Les Funtleyder, Principal CFO | ||
| Corwin Hooks, Chief Officer | ||
| Shoshana Shendelman, Founder, Directors |
Applied Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Applied Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.73 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (243.80) % | ||||
| Current Valuation | 106.73 M | ||||
| Shares Outstanding | 116.36 M | ||||
| Shares Owned By Insiders | 5.23 % | ||||
| Shares Owned By Institutions | 94.77 % | ||||
| Number Of Shares Shorted | 13.56 M | ||||
| Price To Earning | (7.46) X | ||||
| Price To Book | 34.56 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.